Bio-Path
is a Texas-based biotechnology company that researches and develops DNA therapeutics for the treatment of acute myeloid leukemia and solid tumors... Read moreBio-Path
is a Texas-based biotechnology company that researches and develops DNA therapeutics for the treatment of acute myeloid leukemia and solid tumors... Read more
Co-Founder & CEO
Peter Nielsen
2007
PublicNASDAQBPTH
News
May 20, 2026
Benzinga
Bio-Path: Bio-Path Holdings Q1 EPS $(0.03) Up From $(0....
May 14, 2026
EIN Presswire
Press Release: Bio-Path : BIO-PATH ANNOUNCES REPOSITIONING TO SUPPORT GROWTH, ADDS SCIENTIFIC ADVISORS, ENGAGES BANKERS, CANCELS REVERSE SPLIT
Mar 25, 2026
Marketscreener
Bio-Path: Bio-Path Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
Jan 13, 2026
Marketscreener
Bio-Path: Bio-Path Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
Nov 06, 2025
Americanbankingnews
Bio-Path: Bio-Path (BPTH) Projected to Post Earnings on Thursday
Jun 09, 2025
Benzinga
Bio-Path: Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
Jun 04, 2025
citybuzz
Bio-Path: Bio-Path Holdings Advances in RNAi Therapeutics with Promising Clinical Trials
May 15, 2025
Yahoo
Bio-Path: Bio-Path: Q1 Earnings Snapshot
Mar 28, 2025
GlobeNewswire
Press Release: Bio-Path : Bio-Path Holdings Reports Full Year 2024 Financial Results
Mar 28, 2025
Owler
Bio-Path Holdings, Inc.: Bio-Path's employee count had no change from Dec 2023 to Dec 2024
Bio-Path Competitors
1
2
3
4
5
6
7
8
9
10